SAM
PRCT icon

Shell Asset Management’s Procept Biorobotics PRCT Stock Holding History

Shell Asset Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$11K Sell
322
-824
-72% -$37.6K ﹤0.01% 1110
2025
Q2 		$66K Sell
1,146
-127
-10% -$7.18K ﹤0.01% 1095
2025
Q1 		$74K Sell
1,273
-55
-4% -$3.75K ﹤0.01% 1074
2024
Q4 		$107K Sell
1,328
-49
-4% -$4.19K ﹤0.01% 1039
2024
Q3 		$110K Buy
+1,377
New +$97.8K ﹤0.01% 1030
2024
Q1 		$89K Sell
1,458
-124
-8% -$5.9K ﹤0.01% 1051
2023
Q4 		$66K Sell
1,582
-473
-23% -$16.1K ﹤0.01% 1133
2023
Q3 		$67K Sell
2,055
-32
-2% -$1.09K ﹤0.01% 1157
2023
Q2 		$74K Sell
2,087
-12
-0.6% -$397 ﹤0.01% 1172
2023
Q1 		$60K Sell
2,099
-7
-0.3% -$247 ﹤0.01% 1168
2022
Q4 		$87K Sell
2,106
-354
-14% -$15.2K ﹤0.01% 1187
2022
Q3 		$102K Sell
2,460
-659
-21% -$26.3K ﹤0.01% 1228
2022
Q2 		$102K Buy
+3,119
New +$113K ﹤0.01% 1277

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Shell Asset Management's PRCT Position: Q3 2025 in Review

Shell Asset Management reduced its Procept Biorobotics (PRCT) stake by 72% in Q3 2025, selling an estimated $37.6K and leaving 322 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #1110.

Shell Asset Management first reported a position in PRCT in Q2 2022 and has held it in 13 quarters since. The position peaked at $110K in Q3 2024. 242 funds tracked by Wall St. Rank hold PRCT as of Q3 2025.

  • Shell Asset Management held 322 shares of Procept Biorobotics worth $11K as of Q3 2025.
  • Shell Asset Management sold 824 Procept Biorobotics shares in Q3 2025, an estimated $37.6K.
  • Procept Biorobotics made up ﹤0.01% of Shell Asset Management's portfolio in Q3 2025, its #1110 holding.
  • Shell Asset Management first reported a position in Procept Biorobotics in Q2 2022 and has held it in 13 quarters since.
  • Shell Asset Management's Procept Biorobotics position peaked at $110K in Q3 2024.
  • 242 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.